2 vaccines and 1 pill have been granted Emergency Use Authorisation (EUA) against Covid variants.

Why in news?

• A game-changing pill and two new vaccines will bolster India’s fight against Covid variants.
• India has granted Emergency Use Authorisation (EUA) to Serum Institute of India’s Covovax, Biological E’s Corbevax and antiviral Covid-19 pill molnupiravir in a significant move.

About the vaccine and pills

• The new vaccines could possibly be used as booster shots in the days to come. With this nod, the number of Covid vaccines which have received emergency use authorisation is now eight.
• Six COVID-19 vaccines — Serum Institute’s Covishield, Bharat Biotech’s Covaxin, Zydus Cadila’s ZyCoV-D, Russia’s Sputnik V and the US-made Moderna and Johnson and Johnson — had already received EUA from the Indian drug regulator earlier.